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Abstract
Background/Aims: Patients requiring haemodialysis have cardiovascular and immune 
dysfunction. Little is known about the acute effects of exercise during haemodialysis. Exercise 
has numerous health benefits but in other populations has a profound impact upon blood 
pressure, inflammation and immune function; therefore having the potential to exacerbate 
cardiovascular and immune dysfunction in this vulnerable population. Methods: Fifteen 
patients took part in a randomised-crossover study investigating the effect of a 30-min 
bout of exercise during haemodialysis compared to resting haemodialysis. We assessed 
blood pressure, plasma markers of cardiac injury and systemic inflammation and neutrophil 
degranulation. Results: Exercise increased blood pressure immediately post-exercise; however, 
1 hour after exercise blood pressure was lower than resting levels (106±22 vs. 117±25 mm 
Hg). No differences in h-FABP, cTnI, myoglobin or CKMB were observed between trial arms. 
Exercise did not alter circulating concentrations of IL-6, TNF-α or IL-1ra nor clearly suppress 
neutrophil function. Conclusions: This study demonstrates fluctuations in blood pressure 
during haemodialysis in response to exercise. However, since the fall in blood pressure 
occurred without evidence of cardiac injury, we regard it as a normal response to exercise 
superimposed onto the haemodynamic response to haemodialysis. Importantly, exercise did 
not exacerbate systemic inflammation or immune dysfunction; intradialytic exercise was well 
tolerated. 
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IntroductionPatients with end-stage renal disease (ESRD) have a substantially increased incidence of 
cardiovascular events and mortality. Many ’traditional’ risk factors influencing cardiovascular 
health are not pertinent for ESRD patients [1]; factors such as inflammation, malnutrition 
and intradialytic hypotension are more evidently associated with poor survival [2, 3].
Uraemia and haemodialysis (HD) provides increased opportunities for endotoxin influx, 
recurrent infections and immune activation leading to chronic systemic inflammation [4]. ESRD patients consequently have a dysfunctional immune system that is both chronically 
over-activated and anergic [5, 6]. In addition, HD is associated with myocardial demand 
ischaemia that leads to transient myocardial stunning, often with concomitant intradialytic hypotension [7]. Repeated bouts of myocardial stunning are associated with a reduced ejection fraction and increased likelihood of mortality. Both of these factors (immune and myocardial dysfunction) are crucial in the pathogenesis of cardiovascular mortality that is so common in ESRD patients.ESRD patients are highly inactive and this is exacerbated on days when they have 
HD treatment [8, 9]; further, poor physical performance is associated with mortality and 
hospitalisation rates and poor arterial and heart function [10, 11]. As with most populations, 
regular exercise is reported to have numerous benefits for early CKD, HD and transplant 
patients. These include improved exercise capacity, quality of life and cardiovascular health [12-15].Exercise during HD is feasible and compliance and drop-out rates are better compared 
to exercise programmes for HD patients away from dialysis [16, 17]. Intradialytic exercise occurs at a time when patients are otherwise completely sedentary and is an effective way 
to change the exercise culture and behaviour of HD patients [18, 19]. Exercise in healthy 
populations has been suggested as an effective means to reduce systemic inflammation 
[20]; however, an acute bout of exercise also has notable effects on blood pressure [21] and 
immune function [22]. Exercise, for example, can stimulate a muscular release of IL-6 into 
circulation; usually met by an anti-inflammatory response to restore resting levels [23]. ESRD patients are highly vulnerable and the dysfunctional immune and cardiovascular systems in these patients may not adequately respond to the profound transient effects on 
blood pressure, circulating markers of inflammation, and immune function that can occur 
with exercise. Little is known of the immediate impact of exercising during HD, a time when 
patients are at an even greater susceptibility to infection, inflammation and haemodynamic alterations.The aims of this study were to analyse the immediate effects of a bout of physical exercise 
during HD on haemodynamic stability, circulating markers of inflammation and aspects of immune function compared to a usual-care HD session.
Subjects and Methods
Participants
A pragmatic sample of 15 HD patients who were regularly exercising during HD as part of a service development programme gave informed consent to participate in the study and all patients completed both 
study periods (Figure 1), their basic characteristics are described in Table 1.
Patients were recruited from a satellite haemodialysis unit in the University Hospitals of Leicester NHS 
trust. The study received approval from the NHS Research Ethics Committee (ref. 10/H0406/36). Patients 
were not eligible if they were under 18 years, had established contraindications to exercise [24], lower limb 
vascular access, recent clinically overt infection, prescribed immunosuppressive therapy, or an insufficient 
command of English to consent. All patients used polysulfone high-flux dialysers. The dialysate, dialyser, needle size and dialysis duration and prescriptions were unchanged between study days.
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OutcomesBlood pressure was taken using an electronic 
sphygmomanometer at the start of dialysis (0 min), and then at the same time as blood samples drawn directly 
from the HD lines pre-exercise (60 min), immediately 
post-exercise (100 min), 1 h post-exercise (160 min) 
and at the end of dialysis (240 min) and the equivalent times during the control HD session. Rate pressure pro-duct (RPP) was calculated as heart rate x SBP.
HaematologyHaematology and a differential white cell count 
were measured using an automated cell counter (Ac.T 
5diff OV, Beckman Coulter, High Wycombe, UK). Outco-me measures are adjusted for changes in plasma volume 
[26].
Circulating markers of systemic inflammation and 
cardiac injury
Plasma concentrations of IL-6, TNF-α, IL-1ra (R&D 
systems, Abingdon, UK) and CRP (IBL International 
Table 1. Patients’ characteristics
Fig. 1. Flow of participants into and through the study. 
Study designPatients participated in two trial arms during HD treatment usually sepa-rated by a week and carried out on the same day of the week. During the exer-cise arm patients performed a 5-min 
warm-up followed by a 30-min bout of intradialytic exercise using a special-
ly-designed cycle ergometer (Letto se-
ries; Reck, Germany) 60 min into their HD session. Patients cycled at self-selec-ted gears at a perceived exertion of ‘so-mewhat hard’ using the Rating of Percei-ved Exertion scale (RPE) [25]. RPE and power output were recorded every 5 min with participants encouraged to ad-just the gear to match the required RPE. Patients were familiar with the cycle er-gometer and RPE scale from routinely taking part in an exercise programme at 
the renal unit for at least 3 months. Exer-
cise was not novel for these patients, but instead represents the usual effect of exercise during HD for patients that regularly take part in intradialytic exer-cise. During the control arm the patient rested throughout HD.
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GmbH, Hamburg, Germany) were measured using commercially available ELISA kits. Simultaneous detec-
tion of early (heart-type fatty acid-binding protein [h-FABP] and myoglobin) and late (cardiac troponin I 
[cTnI] and creatine kinase MB [CKMB]) markers of myocardial injury were assessed using a commercially 
available biochip assay and Evidence Investigator (Randox Ltd., Crumlin, UK). 
Monocyte phenotyping
10 μL CD14-fluorescein isothiocyanate and 10 μL CD16-phycoerythrin (Becton Dickinson [BD] 
Biosciences, Oxford, UK) were added to 120 μL heparinised whole blood and incubated on ice in the dark 
for 20 min. Erythrocytes were lysed (FACS lysis buffer, BD Biosciences, Oxford, UK) and the cells washed through addition of chilled phosphate buffered saline (PBS) containing 0.5% bovine serum albumin and 2 
mmol/L EDTA. After centrifugation the cells were resuspended in 400 μL chilled PBS solution and analysed 
by flow cytometry (FACSCalibur, BD Biosciences, Oxford, UK). 100,000 events were collected per analysis.
Monocyte populations were identified using CellQuest software (BD Biosciences, Oxford, UK). 
Neutrophils were eliminated using side-scatter vs. CD16. Monocytes identified on morphology were then 
grouped into three phenotypes; CD14++CD16- (classical), CD14++CD16+ (intermediate) and CD14+CD16++ 
(non-classical) [27], CD14-CD16- were disregarded as non-monocytes.
Neutrophil degranulation
1 mL heparinised blood was added to 50 μL bacterial extract (10 mg/mL, Sigma-Aldrich, Gillingham, 
UK) and another 1 mL blood left unstimulated. Samples were incubated at 37 °C for 60 min with gentle 
inversion after 30 min. Samples were centrifuged at 13,000 x g for 2 min and the supernatant harvested. Plasma elastase was assessed in the bacterially-stimulated and unstimulated samples using a commercially 
available ELISA specific for polymorphonuclear cell elastase (BioVendor GmbH, Heidelberg, Germany). 
Omitted samplesOne patient did not provide consent for blood sample collection and data is only included for blood 
pressure. Sufficient blood volume for all outcome measures could not be obtained from two patients; the number of patients included for each outcome measure is described. One participant was excluded from 
cytokine data due to a difference of >5 mg/L in CRP between exercise and control study periods. Outliers 
were excluded from specific outcome measures if values were more than two orders of standard deviation 
different from the group mean, or if unstimulated plasma elastase >500 μg/L. Monocyte phenotypes could 
not be defined in one patient due to unclear fluorescence patterns and were excluded from this analysis.Statistical analysis was repeated including omitted samples with no change to the results; likewise 
for completeness, analysis was repeated before adjustment for plasma volume changes without change to the results.    
Randomisation
The trial was organised in a randomised-crossover design using a website designed specifically for research randomisation to determine order [28].
BlindingThe nature of the exercise intervention precluded blinding.
StatisticsTreatment conditions and baseline differences between arms were compared using paired t-tests or 
Wilcoxon signed-ranks tests where applicable. Two-factor repeated measures ANOVA was used to analyse 
data: trial arm (exercise vs. control) x time. Where data was non-normally distributed (Shapiro-Wilk) 
ANOVA was performed on the logarithmic transformation of the data and reported in original form. If the 
omnibus test found a significant effect post hoc paired t-tests and repeated contrasts were used and adjusted 
for multiple comparisons using the Holm-Bonferroni method [29]. Effect sizes (ES) were calculated using 
Cohen’s D. Statistical analysis was performed on Statistical Package for Social Sciences (SPSS v.21, IBM, New 
York, USA). Data is presented as mean ± standard deviation or median (interquartile range) as described. 
Statistical significance was accepted at P<0.05.
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(P<0.001; ES=0.78; Table 3). Consequently, the rate pressure product (RPP) was signifi-cantly higher immediately post-exercise compared with the control arm (P<0.001; ES=1.15; 
Table 3), this fell subsequently with a trend for lower RPP 1 h post-exercise (P=0.08; ES=0.47) 
and significantly lower at the completion of HD (P=0.02; ES=0.15).
Haematology and monocyte phenotypes
Exercise had no significant effect on total or differentiated leukocyte counts 
(Table 4). The proportion of intermediate monocytes fell during HD in both arms (effect of time: P=0.002), the proportion was lower at the end of HD compared to the first sample (P=0.006; ES=0.80). Trends for an effect of exercise on intermediate and non-classical 
Fig. 2. Systolic and diastolic blood pressure throughout haemodialysis in the exercise ( ) and control ( ) trial arms. The grey bar 
represents the 30 min of exercise completed on the exercise study 
period. Ex: Exercise. Data is presented as mean ± standard error 
(n = 15). A significant main effect of time (P < 0.001) and a time*trial arm interaction (P < 0.001) were observed. * denotes a significant differences between arms at that time. 
Table 2. Haemodialysis treatment variables on exercise and control trial armsResults
Exercise and Haemodial-
ysis
All fifteen recruited pa-tients successfully completed 
30 min of cycling starting 60 
min into HD, as well as the comparator HD period wi-thout exercise. The patients reported the exercise as “so-
mewhat hard”; specifically, an 
RPE of 13±1. The mean pow-er output was measured as 
21.5±8.1 W.Parameters of haemodia-lysis treatment were not diffe-rent between the arms (Table 
2). Prescribed medications, 
haemodialysis and ultrafiltra-
tion did not vary. No adverse events were reported.
Haemodynamic parame-
ters
In both arms, systolic blood pressure (SBP) fell af-ter initiation of HD (P≤0.007; 
ES≥0.84; Figure 2). SBP was 
significantly higher immedia-tely after exercise compared 
to the control arm (125±18 
vs. 112±20 mm Hg; P=0.03; 
ES=0.71). However, 1 h af-ter completion of exercise SBP had fallen and was si-
gnificantly lower than con-
trols (106±22 vs. 117±25 mm Hg; P=0.04; ES=0.46), there were no differences at the end of HD. Heart rate was elevated post-exercise 
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monocytes were observed (Table 4). The proportion of intermediate monocytes appeared to fall by a greater amount in the exercise arm (interaction: P=0.09) but post hoc tests were 
not statistically significant (P>0.17). The proportion of non-classical monocytes appeared to increase immediately post-exercise (interaction: P=0.08), post hoc tests found no statistically 
significant differences (P>0.14).   
Markers of systemic inflammation
Exercise had no effect on circulating concentrations of IL-6, TNF-α or IL-1ra (Table 4). 
Across both arms IL-6 appeared to increase during HD (effect of time: P=0.03) although 
post hoc tests were not statistically different (P>0.17). Conversely, TNF-α decreased during HD across both arms (effect of time: P=0.004), at the end of HD TNF-α concentrations were 
significantly lower than the pre-exercise sample (P=0.04, ES=0.68). CRP was measured at 
the 60-min time-point as a reference marker of systemic inflammation and concentrations 
were similar between trial arms (Table 4, P=0.7). 
Circulating markers of cardiac injury
Exercise had no significant effects on h-FABP, myoglobin, CKMB or cTnI (Table 3). h-FABP 
and myoglobin significantly fell during both arms suggesting a clearance through HD (effect of time: both P<0.001); no anomalies or outliers were observed. Similarly, CKMB showed a trend for a reduction across both arms (effect of time: P=0.06). The majority of cTnI results 
were below the limits of detection, there was no pattern for increasing concentrations of 
cTnI. 
Neutrophil degranulationUnstimulated plasma elastase increased in both arms but with no effect of exercise (effect of time: P=0.05; Table 4). Neither HD nor exercise had a significant effect on the 
total neutrophil response to bacterial stimulation. After adjustment to degranulation per 
neutrophil an effect of exercise was observed (Table 4); despite an apparent trend for suppressed responsiveness post-exercise post hoc paired t-tests and repeated contrasts 
found no significant differences between arms (P>0.096).
Table 3. Acute effects of exercise on haemodynamic parameters and markers of cardiac injury 
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Discussion
Exercise at an intensity that patients found achievable during HD was sufficient to 
cause a significant increase in SBP during exercise followed by notable post-exercise hypotension. These deviations in blood pressure occurred without increasing markers of 
myocardial damage. Further, intradialytic exercise did not exacerbate circulating markers of 
inflammation or immune dysfunction. Other studies have also observed an increase in SBP during a bout of intradialytic exercise 
from as little as 10 min duration [30-32]. These studies concluded that exercise during HD is met with a stable haemodynamic response; the cardiovascular response to exercise is 
normal and superimposed onto the response to HD. However, if ultrafiltration volumes are 
high, exercise may be contraindicated later in HD treatment due to gradually decreasing 
blood pressure and cardiac output [33]. Normally, the maintenance of blood pressure during HD is crucial and exacerbation of intradialytic hypotension may be detrimental to 
Table 4. Acute effects of exercise on markers of systemic inflammation, haematology and neutrophil de-granulation  
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health [34]. Exercise places an additional demand upon the heart (as seen by the RPP) at a 
time when it is at an increased susceptibility to demand ischaemia, potentially increasing the risk of myocardial stunning and left ventricular dysfunction [7]. The post-exercise hypotension witnessed therefore theoretically suggests an increased risk of myocardial 
injury. Reassuringly however, markers of cardiac injury were not different between arms 
and considering both cTnI and h-FABP have good sensitivity and specificity for detecting 
myocardial damage in the immediate aftermath of a cardiac event [35, 36].The observed fall in blood pressure post-exercise is not exclusive to intradialytic exercise. Extensive reviews of ‘post-exercise hypotension’ in the general population show SBP is frequently decreased in the hours following exercise. The response in healthy individuals may be negligible but is marked in hypertensive populations [21]. ESRD patients 
typically present with hypertension [37]; moderate-intensity walking exercise in patients 
with earlier stage chronic kidney disease (CKD, stage 2-4) has been shown to significantly 
reduce SBP and DBP during the hour following exercise compared with controls (-6.5 mm 
Hg and -2.5 mm Hg) [38].
Despite the negative associations of intradialytic hypotension, there is no evidence, from 
this or other studies, to suggest exercise causes any subclinical myocardial injury. Elsewhere, 
no serious adverse events have been reported after around 28,000 h of intradialytic exercise 
[13]. Moreover, ESRD patients who regularly exercise during HD improve heart rate 
variability, left ventricular ejection fraction and risk rating of sudden cardiac death [39-41]. Further research is required to delineate myocardial and vascular function during and after intradialytic exercise and the long-term impact of regular training.
Intradialytic exercise had little effect on circulating cytokines or leukocyte counts. In 
the general population circulating concentrations of IL-6 increase after a bout of exercise 
[23]. Despite the potential for exacerbated circulating cytokine concentrations post-exercise 
(reported in other conditions; e.g. COPD [42] and cystic fibrosis [43]) intradialytic exercise 
had no effect. This may be because the exercise stimulus was insufficient, or that a minor 
release was not noticeable above the effects of HD or uraemia, or that uraemia per se inhibits 
the pathway for exercise-induced IL-6 secretion in the muscle as indicated by reduced muscle 
IL-6 mRNA in response to exercise seen in 5/6 nephrectomy rats [44]. Short duration exercise 
has been shown to exacerbate circulating TNF-α concentrations in COPD and heart failure 
patients [45, 46]; reassuringly, this study found no increase in plasma TNF-α after exercise. A recent systematic review highlighted a lack of understanding of the acute effects of exercise 
on inflammatory markers in chronic inflammatory diseases [47]. One recent paper reported 
an increase in IL-10 after HD including 20 min cycling with a similar absence of changes in 
IL-6 and TNF-α [48]. Another study found no immediate change in CRP after intradialytic 
resistance exercise despite a decrease in the antioxidant superoxide dismutase [49]. It is 
therefore reassuring that the present study found no exacerbation of inflammation. Long-
term anti-inflammatory benefits of regular exercise have been observed at low-to-moderate 
intensity that is not associated with an acute release of IL-6 [50]. Whether regular exercise 
of this nature has beneficial anti-inflammatory properties in HD patients is currently unclear [51].
An observable trend for an increase in proportion of non-classical monocytes occurred 
post-exercise. In healthy populations a preferential mobilisation of CD16+ monocytes 
(specifically non-classical) is also observed after exercise [52] and similar results have been 
recently been reported in pre-dialysis CKD patients [53]. Greater expression of adhesion 
molecules on CD16+ monocytes result in a greater proportion of these phenotypes in 
the marginal pool, particularly during HD [54]; it appears exercise causes an enhanced demargination of these cells.
Both exercise and HD may stimulate a spontaneous elastase release [55, 56]. Importantly, intradialytic exercise did not appear to exacerbate spontaneous elastase secretion that increased during HD. Suppressed neutrophil degranulation is apparent after intense 
exercise in healthy individuals [55]; conversely, enhanced neutrophil responsiveness was 
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observed 1 h post-exercise in pre-dialysis CKD patients [57]. Neither a clear improvement nor deterioration was observed here after intradialytic exercise.  Overall it appears that intradialytic exercise at the intensity and duration that HD 
patients could manage in this trial did not exacerbate the circulating inflammatory factors 
measured. The power output, although low, appears comparable to other studies [58] but 
due to the different equipment and programmes used it is difficult to make meaningful comparisons. The effect of altering exercise intensity or duration warrants future research. The UF goal of this cohort of patients is representative of local practice but may be lower 
than seen in other populations (e.g. higher in the US). Larger UF targets may exacerbate alterations in blood pressure. Previous studies have shown that exercise later in HD (after 
three hours) may be contraindicated for individuals with a high UF target [33]; therefore, it seems advisable to consider both these aspects when prescribing exercise. Exercise late 
in HD should be avoided for those susceptible to hypotension or having large fluid volumes removed. There are some limitations to this study which should be acknowledged. This study 
represents a single mode, duration and intensity of exercise; other patterns of exercise may have differing effects. The present mode and intensity was chosen as part of a pragmatic approach on the basis of patient feedback. The patients in this study were accustomed to 
intradialytic exercise, when patients first start an exercise programme and exercise is novel 
a more exaggerated response may occur. Also, it should be noted that patients eligible to take 
part in exercise are healthier with a lower risk of complications [59].The randomised-crossover design allows direct comparisons to be made between the two study periods and reduces the potential impact of confounding elements such as circadian 
rhythm. The sample size precludes definitive conclusions from being made. However, it does inform the design of further investigations examining post-exercise hypotension in HD 
patients, especially to investigate whether a single bout of exercise has prolonged effects on blood pressure and what impact other forms of exercise have. 
Conclusion
In summary, exercise at an intensity that patients are able to complete during HD 
caused an increase in blood pressure during exercise followed by a significant post-exercise 
hypotension. In this instance, the intradialytic hypotension occurred in the absence of myocardial injury and likely represents a normal haemodynamic response to exercise 
superimposed onto the impact of HD. Intradialytic exercise did not exacerbate the pro-
inflammatory environment or immune dysfunction associated with ESRD; therefore, from 
both perspectives, moderate-intensity cycling exercise during HD is well tolerated. 
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